14-3-3ε inhibits premature centriole disengagement by inhibiting the activity of Plk1 and separase
The 14-3-3 protein family regulates several pathways in mammalian cells, including centrosome duplication. However, the precise mechanisms by which 14-3-3 paralogs regulate the centrosome cycle remain unclear. To identify the mechanisms by which 14-3-3ε regulates centrosome duplication, we altered two conserved acidic residues in the 14-3-3ε phospho-peptide-binding pocket that regulate complex formation and dissociation with the associated ligands, D127 and E134, to alanine. Altering these residues to alanine led to opposing effects on centrosome duplication; the D127A mutant inhibited centrosome duplication, whereas cells expressing the E134A mutant showed the presence of supernumerary centrosomes. We demonstrate that 14-3-3ε does not inhibit centriole duplication, as reported for 14-3-3γ, but inhibits centriole disengagement. Using a combination of pharmacological and genetic approaches, we demonstrate that 14-3-3ε inhibits the activity of Plk1 and separase [also known as separin (ESPL1)], leading to disengagement defects that ultimately lead to decreased proliferation and cell death. Our work demonstrates that different 14-3-3 paralogs regulate different steps in the centrosome cycle and that disrupting complex formation between 14-3-3ε and Plk1 or separase could be a novel therapeutic strategy in tumor cells.
Authors
- Sumit Tiwari
- Sorab N. Dalal (ORCID: https://orcid.org/0000-0001-6883-7550)
- Aparna Das
- M. Jaiswal
- Anisha Kumari (ORCID: https://orcid.org/0009-0007-0239-935X)
- Akshay Karn (ORCID: https://orcid.org/0000-0001-6018-6562)
Institutions
- Homi Bhabha National Institute (IN)
- Tata Memorial Hospital (IN)
- Advanced Centre for Treatment, Research and Education in Cancer (IN)
Publication Details
- Journal
- Journal of Cell Science
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1242/jcs.263808
- Citations
- 1
- Primary Topic
- 14-3-3 protein interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Department of Atomic Energy, Government of India
- Advanced Centre for Treatment, Research and Education in Cancer